Antiviral agent 46
Product Specifications
UNSPSC Description
Antiviral agent 46 (compound 4) is a derivative of cannabidiol (CBD) with anti-SARS-CoV-2 (IC50: 1.90 μM) and ACE2 activity (IC50: 1.37 μM)[1].
Target Antigen
Angiotensin-converting Enzyme (ACE); SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection;Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/antiviral-agent-46.html
Solubility
10 mM in DMSO
Smiles
CC1=C[C@@H](C2=C(O)C=C(CCCCC)C=C2O)[C@H](C(C)C)CC1
Molecular Weight
316.48
References & Citations
[1]Marques GVL, et al. Synthesis of cannabidiol-based compounds as ACE2 inhibitors with potential application in the treatment of COVID-19. Eur J Med Chem. 2023 Nov 15;260:115760
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-161070/Antiviral-agent-46-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-161070/
Clinical Information
No Development Reported
CAS Number
9007-83-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items